Freiman JA, Chalmers TC, Smith H, Kuebler RR (1978)
The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. New England Journal of Medicine 299:690-94.
Key articles
- Campbell MJ (2012).
Doing clinical trials large enough to achieve adequate reductions in uncertainties about treatment effects.
- Dickersin K, Chalmers F (2014).
Thomas C Chalmers (1917-1995): a pioneer of randomized clinical trials and systematic reviews.
- Clarke M (2015).
History of evidence synthesis to assess treatment effects: personal reflections on something that is very much alive.